Icana.ir
PrintLogoPrintPrintLogo/Print With Image SendToFriendSend To Friends Whatsapp google_plus Line twitter

Tehran, Havana to mass produce COVID-19 vaccine

Service : Politic
TEHRAN (ICANA) _ Iran and Cuba plan to create the capacity for the manufacturing COVID-19 vaccines amid sanctions imposed on the two countries by the administration of former US President Donald Trump.
Saturday, January 23, 2021 12:00:00 PM

TEHRAN (ICANA) _ Spokesman of Iran Food and Drug Administration (IFDA), Kianoush Jahanpour, made the announcement in a post on his Twitter account on Friday that Iran had nine active cases of the vaccine while Cuba had four and there was one joint project between the two countries.

“Both countries have been under US sanctions for decades and the sanctions have been increased in recent months,” he added.

Iran and Cuba signed an agreement earlier this month to cooperate in the coronavirus vaccine project with the use of a technology that will be transferred to Iran by the Cuban government.

The vaccine, known as ‘Subrana 2,’ is now undergoing the human phase trials by the Cuban Finlay Institute and the Pasteur Institute of Iran.

The medicine, which is the most advanced one among Cuba’s four other coronavirus vaccines, has so far shown no side effects, as the initial stages of its testing have been completed successfully.

In another tweet on Friday, Jahanpour said Cuba plans to launch the Phase-III clinical trials for 150,000 candidates of COVID-19 vaccine while 50,000 candidates would attend this phase in Iran at the same time.

The Iranian health official emphasized that the vaccine’s clinical trials will be conducted in Cuba on children and the young people.

Iran has already launched human trials of its first domestic coronavirus vaccine.

The vaccine, known as COViran Barekat, is being produced under the health protocols and guidelines announced by the Iranian Ministry of Health and Medical Education.

The sanctions have hampered Iran’s access to medical equipment and pharmaceuticals, complicating the process of importing vaccines from overseas.

A second domestic vaccine has also been approved by both IFDA and the Iranian National Committee for Ethics in Biomedical Research.

Member Comments
Full Name :
Email :
Body :

fa Icana

Copyright © Icana All Rights Reserved

Powerd By : Tasvirnet